Women’s Hormones Printer Friendly Version
  page: 3 of 4
pages: <<Prev 1 2 3 4 Next>> published on: 8 August 2002
 

Cardiovascular Disease

A large US study of cardiovascular risk factors in women taking various estrogen / progestin replacement regimens was published in the Journal of the American Medical Association. 2 Referred to as the PEPI Trial, it confirmed the fact that synthetic progestins partially negate the beneficial effects on cholesterol levels that result from taking estrogen. Natural progesterone, on the other hand, maintains all the benefits of estrogen on cholesterol without any of the side effects associated with synthetic progestins (such as fluid retention, irritability and depression).

Menopause

Mayo Clinic researchers surveyed 176 women taking natural micronised progesterone who had previously taken synthetic progestins to see if natural progesterone, when compared to synthetics, made a difference in the women’s overall quality of life, menopausal symptoms, and satisfaction with HRT. After one to six months, the women reported an overall 34% increase in satisfaction on micronised progesterone compared to their previous HRT.

Miyagawa and Frank of Oregon Health Sciences University showed that progesterone plus estradiol protected against vasospasm, but estradiol did not. Based on the results presented here, formulations of natural progesterone would appear to offer the wiser alternative. 3

Osteoporosis

Dr John Lee, in his book Natural Progesterone prescribes natural progesterone, a diet rich in vegetables and grains to serve as a source of calcium and magnesium and modest exercise. Dr. Lee conducted a study of 100 postmenopausal women. Bone mineral density (BMD) was monitored and observed an increase in BMD by 15% ( indicating a reversal of osteoporosis) . Therapy produced relief of bone pain, increased physical activity, height stabilisation and fracture prevention. The benefits of progesterone were independent of age, time from menopause, or estrogen use. 4

Osteoporosis is a “silent” disease affecting 4 times more women than men. Menopause is a known risk factor for women. Hospital costs to address Osteoporosis in Australia currently exceed $800 million per year and is growing.

Osteoporosis is preventable and treatable; but because there are no warning signs until fracture occurs, few people are currently being diagnosed in time to receive effective therapy during the disease’s early phase.

BHRT not only slows the loss of bone but also increases bone density, which helps to decrease the possibility of new fractures. Estrogen replacement therapy is approved for both the prevention and treatment of osteoporosis, and is effective even when started after age 70. Studies indicate that progesterone plays an important role in regulating new bone formation. Progesterone therapy is important because increased resorption (bone loss) which occurs after menopause will not cause a net loss of bone if it is offset by new bone formation. Testosterone therapy may also be utilised to improve bone health. Natural HRT, using bio-identical hormones, may minimise side effects of hormone replacement therapy. Working together with patient and physician, we can compound customised natural HRT to meet your unique needs.
The role of natural progesterone as a bone-trophic hormone was demonstrated by Dr. Prior in the progesterone receptors in osteoblasts which mediate new bone formation. 5

Natural Estrogens

Estrogen is not a hormone, but a group of similar hormones with varying degrees of activity. The three most important hormones of this class are estrone (E1), estradiol (E2), and estriol (E3). Estradiol is the primary estrogen produced by the ovary, and estrone is formed by conversion of estradiol. Estrone is thought to be the estrogen primarily responsible for breast cancer. Estriol is produced in very large amounts during pregnancy and is proven to be protective against breast cancer. As far back as 1978, in the Journal of the American Medical Association, Dr. Alvin Follingstad advocated the use of the safer form of estrogen, estriol. He reported that 37% of postmenopausal women with metastatic breast cancer who received small doses of estriol had experienced remission or arrest of the metastatic tumors. 6



pages:<<Prev 1 2 3 4 Next>>